Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome
1Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
Insights
The gastrocardiac syndrome links gut inflammation, like Helicobacter pylori infection, to heart issues. Managing these conditions may reduce cardiovascular events and gastrointestinal bleeding risks.
Area of Science:
- Gastroenterology and Cardiology
- Gastrocardiology
Background:
- The gastrocardiac syndrome, initially described in the 19th century, referred to gastric issues mimicking cardiac pain.
- A modern view links chronic systemic inflammation from gastrointestinal conditions (e.g., inflammatory bowel disease, Helicobacter pylori infection) to cardiovascular risk.
- Cardiovascular treatments, particularly antithrombotics, necessitate balancing benefits against increased gastrointestinal bleeding risks.
Purpose of the Study:
- To explore the contemporary relevance of the gastrocardiac syndrome.
- To highlight the interplay between gastrointestinal inflammation, Helicobacter pylori, and cardiovascular disease.
- To discuss strategies for managing gastrointestinal inflammation and Helicobacter pylori to mitigate cardiovascular and bleeding risks.
Main Methods:
- Review of existing literature on gastrocardiac syndrome, systemic inflammation, and cardiovascular disease.
- Analysis of the risks and benefits of current treatments for cardiovascular disease and gastrointestinal conditions.
- Discussion of potential diagnostic and therapeutic strategies for gastrocardiac conditions.
Main Results:
- Chronic systemic inflammation from gastrointestinal issues is a significant cardiovascular risk factor.
- Helicobacter pylori infection is implicated in both gastrointestinal and cardiovascular pathology.
- Balancing antithrombotic therapy benefits with gastrointestinal bleeding risks is crucial.
Conclusions:
- The gastrocardiac syndrome remains highly relevant, bridging gastroenterology and cardiology.
- Targeting gastrointestinal inflammation and Helicobacter pylori may reduce adverse cardiovascular and bleeding events.
- A dedicated Gastro-cardiology subspecialty could improve patient outcomes by addressing these interconnected conditions.
Abstract:
The gastrocardiac syndrome was coined originally at the beginning of the 19th century to describe an alleged gastric-cardiopathy with reflux heartburn mimicking cardiac chest pain. Today, a wider perspective of gastrocardiac syndrome has emerged. First, the cardiovascular risk factor chronic systemic inflammation may reflect gastroenterological inflammatory conditions, such as inflammatory bowel disease and gastrointestinal infections, in particular, chronic Helicobacter pylori infection. Furthermore, since contemporary treatment of cardiovascular disease commonly includes potent antithrombotic medications, the cardiovascular benefit in terms of a decrease in the incidence of recurrent ischemic events and death needs to be carefully balanced with an increased risk of gastrointestinal bleeding. Several strategies to target chronic gastrointestinal inflammation and to diagnose and treat Helicobacter pylori to reduce the risk of cardiovascular events and gastrointestinal bleeding are available but residual controversy remains and large-scale gastro-cardiology trials are needed to determine the optimal treatment approaches. In perspective, the centennial gastrocardiac syndrome is more relevant than ever in a contemporary gastroenterology and cardiology setting. A collaborative subspecialty, namely Gastro-cardiology, would introduce novel unique means to study, diagnose and treat gastrocardiac conditions with the aim to reduce the risk of cardiovascular and bleeding events to improve the prognosis for gastro-cardiology patients.
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:29Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
01:30Acute Coronary Syndrome I: Introduction
01:25Cardiomyopathy I: Introduction and Classification
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy